United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (2008). FDA's foreign drug inspection program: Weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. FDA's Foreign Drug Inspection Program: Weaknesses Place Americans at Risk : Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, Second Session, April 22, 2008. Washington: U.S. G.P.O., 2008.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. FDA's Foreign Drug Inspection Program: Weaknesses Place Americans at Risk : Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, Second Session, April 22, 2008. U.S. G.P.O., 2008.